Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine in Second-line Gastric Cancer
NCT00359476Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2007
- Primary completion
- Oct 2007
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of vinflunine in gastric cancer (GC), sponsored by Bristol Myers Squibb. Started Mar 2007; status: terminated.
02
Drugs
vinflunine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00359476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359476.